FREMONT, Calif., Sept. 17 Quark Pharmaceuticals, Inc., adevelopment-stage pharmaceutical company discovering and developing novel RNAinterference (RNAi)-based therapeutics, today announced the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback